BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 22537137)

  • 1. Immunity after (re)vaccination of paediatric patients following haematopoietic stem cell transplantation.
    Olkinuora H; Käyhty H; Davidkin I; Roivainen M; Olander RM; Kantele JM; Siitonen S; Vettenranta K
    Acta Paediatr; 2012 Aug; 101(8):e373-7. PubMed ID: 22537137
    [TBL] [Abstract][Full Text] [Related]  

  • 2. VaccHemInf project: protocol for a prospective cohort study of efficacy, safety and characterisation of immune functional response to vaccinations in haematopoietic stem cell transplant recipients.
    Conrad A; Boccard M; Valour F; Alcazer V; Tovar Sanchez AT; Chidiac C; Laurent F; Vanhems P; Salles G; Brengel-Pesce K; Meunier B; Trouillet-Assant S; Ader F;
    BMJ Open; 2019 Feb; 9(2):e026093. PubMed ID: 30772864
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Vaccination].
    Graubner UB; Liese J; Belohradsky BH
    Klin Padiatr; 2001 Sep; 213 Suppl 1():A77-83. PubMed ID: 11577366
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of early viral infections and graft-versus-host disease on immune reconstitution following paediatric stem cell transplantation.
    Olkinuora H; von Willebrand E; Kantele JM; Vainio O; Talvensaari K; Saarinen-Pihkala U; Siitonen S; Vettenranta K
    Scand J Immunol; 2011 Jun; 73(6):586-93. PubMed ID: 21323694
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vaccination of allogeneic haematopoietic stem cell transplant recipients: report from the international consensus conference on clinical practice in chronic GVHD.
    Hilgendorf I; Freund M; Jilg W; Einsele H; Gea-Banacloche J; Greinix H; Halter J; Lawitschka A; Wolff D; Meisel R
    Vaccine; 2011 Apr; 29(16):2825-33. PubMed ID: 21345379
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Revaccination with measles, tetanus, poliovirus, Haemophilus influenzae type B, meningococcus C, and pneumococcus vaccines in children after hematopoietic stem cell transplantation.
    Patel SR; Ortín M; Cohen BJ; Borrow R; Irving D; Sheldon J; Heath PT
    Clin Infect Dis; 2007 Mar; 44(5):625-34. PubMed ID: 17278051
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Status of immunity for vaccine--preventable diseases in children after hematopoietic stem cells transplantation.
    Goździk J; Czajka H; Paradowska-Stankiewicz I; Skoczeń S; Czogała W; Krasowska-Kwiecień A; Wiecha O
    Przegl Epidemiol; 2012; 66(1):93-8. PubMed ID: 22708306
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Humoral immunity to diphtheria, tetanus, measles, and hemophilus influenzae type b in children with acute lymphoblastic leukemia and response to re-vaccination.
    Zengin E; Sarper N
    Pediatr Blood Cancer; 2009 Dec; 53(6):967-72. PubMed ID: 19544393
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Humoral immunity to viral and bacterial antigens in lymphoma patients 4-10 years after high-dose therapy with ABMT. Serological responses to revaccinations according to EBMT guidelines.
    Nordøy T; Husebekk A; Aaberge IS; Jenum PA; Samdal HH; Flugsrud LB; Kristoffersen AC; Holte H; Kvaløy S; Kolstad A
    Bone Marrow Transplant; 2001 Oct; 28(7):681-7. PubMed ID: 11704791
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibody responses to vaccinations given within the first two years after transplant are similar between autologous peripheral blood stem cell and bone marrow transplant recipients.
    Gandhi MK; Egner W; Sizer L; Inman I; Zambon M; Craig JI; Marcus RE
    Bone Marrow Transplant; 2001 Oct; 28(8):775-81. PubMed ID: 11781630
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Measles immunity after allogeneic stem cell transplantation; influence of donor type, graft type, intensity of conditioning, and graft-versus host disease.
    Ljungman P; Aschan J; Barkholt L; Broliden PA; Gustafsson B; Lewensohn-Fuchs I; Löfgren C; Winiarski J; Ringdén O
    Bone Marrow Transplant; 2004 Oct; 34(7):589-93. PubMed ID: 15300234
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibody response to polysaccharide conjugate vaccines after nonmyeloablative allogeneic stem cell transplantation.
    Meerveld-Eggink A; van der Velden AM; Ossenkoppele GJ; van de Loosdrecht AA; Biesma DH; Rijkers GT
    Biol Blood Marrow Transplant; 2009 Dec; 15(12):1523-30. PubMed ID: 19896075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Allogeneic hematopoietic stem cell transplantation recipients have defects of both switched and igm memory B cells.
    D'Orsogna LJ; Wright MP; Krueger RG; McKinnon EJ; Buffery SI; Witt CS; Staples N; Loh R; Cannell PK; Christiansen FT; French MA
    Biol Blood Marrow Transplant; 2009 Jul; 15(7):795-803. PubMed ID: 19539210
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vaccination against infectious disease following hematopoietic stem cell transplantation.
    Avigan D; Pirofski LA; Lazarus HM
    Biol Blood Marrow Transplant; 2001; 7(3):171-83. PubMed ID: 11302551
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Response to measles, mumps and rubella vaccine in paediatric bone marrow transplant recipients.
    King SM; Saunders EF; Petric M; Gold R
    Bone Marrow Transplant; 1996 Apr; 17(4):633-6. PubMed ID: 8722367
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lack of serologic immunity against vaccine-preventable diseases in children after thoracic transplantation.
    Urschel S; Cremer S; Birnbaum J; Dallapozza R; Fuchs A; Jäger G; Schmitz C; Belohradsky BH; Netz H
    Transpl Int; 2010 Jun; 23(6):619-27. PubMed ID: 20028497
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An Immune Recovery-Based Revaccination Protocol for Pediatric Hematopoietic Stem Cell Transplant Recipients: Revaccination Outcomes Following Pediatric HSCT.
    Haynes AS; Curtis DJ; Campbell K; Giller RH; Quinones RR; Verneris MR; Abzug MJ
    Transplant Cell Ther; 2021 Apr; 27(4):317-326. PubMed ID: 33836875
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Longitudinal analysis of antibody response to immunization in paediatric survivors after allogeneic haematopoietic stem cell transplantation.
    Inaba H; Hartford CM; Pei D; Posner MJ; Yang J; Hayden RT; Srinivasan A; Triplett BM; McCulllers JA; Pui CH; Leung W
    Br J Haematol; 2012 Jan; 156(1):109-17. PubMed ID: 22017512
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomized study on donor immunization with tetanus-diphtheria, Haemophilus influenzae type b and inactivated poliovirus vaccines to improve the recipient responses to the same vaccines after allogeneic bone marrow transplantation.
    Parkkali T; Käyhty H; Hovi T; Olander RM; Roivainen M; Volin L; Ruutu T; Lahdenkari M; Ruutu P
    Bone Marrow Transplant; 2007 Feb; 39(3):179-88. PubMed ID: 17211432
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibody responses to tetanus toxoid and Haemophilus influenzae type b conjugate vaccines following autologous peripheral blood stem cell transplantation (PBSCT).
    Chan CY; Molrine DC; Antin JH; Wheeler C; Guinan EC; Weinstein HJ; Phillips NR; McGarigle C; Harvey S; Schnipper C; Ambrosino DM
    Bone Marrow Transplant; 1997 Jul; 20(1):33-8. PubMed ID: 9232253
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.